Furst D - Search Results

1

Steady-state serum salicylate levels in hospitalized patients with rheumatoid arthritis. Comparison of two dosage schedules of choline magnesium trisalicylate.

Cassell S, Furst D, Dromgoole S, Paulus H. Cassell S, et al. Among authors: furst d. Arthritis Rheum. 1979 Apr;22(4):384-8. doi: 10.1002/art.1780220411. Arthritis Rheum. 1979. PMID: 426883

2

A controlled study of concurrent therapy with a nonacetylated salicylate and naproxen in rheumatoid arthritis.

Furst DE, Blocka K, Cassell S, Harris ER, Hirschberg JM, Josephson N, Lachenbruch PA, Trimble RB, Paulus HE. Furst DE, et al. Arthritis Rheum. 1987 Feb;30(2):146-54. doi: 10.1002/art.1780300204. Arthritis Rheum. 1987. PMID: 3548732 Clinical Trial.

3

Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritis.

Furst DE, Sarkissian E, Blocka K, Cassell S, Dromgoole S, Harris ER, Hirschberg JM, Josephson N, Paulus HE. Furst DE, et al. Arthritis Rheum. 1987 Oct;30(10):1157-61. doi: 10.1002/art.1780301011. Arthritis Rheum. 1987. PMID: 3675660

4

Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.

Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE. Khanna D, et al. Among authors: furst de. Arthritis Rheum. 2005 Oct;52(10):3030-8. doi: 10.1002/art.21295. Arthritis Rheum. 2005. PMID: 16200612 Free article. Clinical Trial.

5

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, et al. Felson DT, et al. Among authors: furst d. Arthritis Rheum. 1995 Jun;38(6):727-35. doi: 10.1002/art.1780380602. Arthritis Rheum. 1995. PMID: 7779114

6

A strategy for reaching therapeutic salicylate levels in patients with rheumatoid arthritis using standardized dosing regimens.

Furst DE, Blocka K, Cassell S, Dromgoole S, Harris ER, Hirschberg JM, Josephson N, Rupp PA, Paulus HE, Trimble RB. Furst DE, et al. J Rheumatol. 1987 Apr;14(2):342-7. J Rheumatol. 1987. PMID: 3599003

7

Availability of salicylate from salsalate and aspirin.

Dromgoole SH, Cassell S, Furst DE, Paulus HE. Dromgoole SH, et al. Among authors: furst de. Clin Pharmacol Ther. 1983 Oct;34(4):539-45. doi: 10.1038/clpt.1983.211. Clin Pharmacol Ther. 1983. PMID: 6617077

8

Single dose pharmacokinetics of auranofin in rheumatoid arthritis.

Blocka K, Furst DE, Landaw E, Dromgoole S, Blomberg A, Paulus HE. Blocka K, et al. Among authors: furst de. J Rheumatol Suppl. 1982 Jul-Aug;8:110-9. J Rheumatol Suppl. 1982. PMID: 6813473

9

Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteers.

Furst DE, Dromgoole SH, Desiraju RK, Paulus HE. Furst DE, et al. J Clin Pharmacol. 1983 Jul;23(7):329-35. doi: 10.1002/j.1552-4604.1983.tb02743.x. J Clin Pharmacol. 1983. PMID: 6886031

10

Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis.

Day RO, Furst DE, Dromgoole SH, Kamm B, Roe R, Paulus HE. Day RO, et al. Among authors: furst de. Clin Pharmacol Ther. 1982 Jun;31(6):733-40. doi: 10.1038/clpt.1982.103. Clin Pharmacol Ther. 1982. PMID: 7075121 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,034 results

Search Page

Filters